Total Payments
$9,984
2024 Payments
$2,939
Companies
47
Transactions
535
Medicare Patients
2,257
Medicare Billing
$298,443
Payment Breakdown by Category
Food & Beverage$9,773 (97.9%)
Education$210.39 (2.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,773 | 527 | 97.9% |
| Education | $210.39 | 8 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,330 | 70 | $0 (2024) |
| Novo Nordisk Inc | $957.93 | 59 | $0 (2024) |
| Abbott Laboratories | $865.31 | 59 | $0 (2024) |
| Amgen Inc. | $668.08 | 31 | $0 (2024) |
| Insulet Corporation | $514.67 | 16 | $0 (2024) |
| Radius Health, Inc. | $447.20 | 27 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $436.87 | 31 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $362.02 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $297.79 | 19 | $0 (2024) |
| Antares Pharma, Inc. | $276.78 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,939 | 146 | Abbott Laboratories ($378.17) |
| 2023 | $2,443 | 129 | Lilly USA, LLC ($416.48) |
| 2022 | $1,993 | 109 | Lilly USA, LLC ($301.89) |
| 2021 | $1,993 | 118 | Novo Nordisk Inc ($308.95) |
| 2020 | $573.75 | 31 | Antares Pharma, Inc. ($70.33) |
| 2019 | $20.11 | 1 | Amgen Inc. ($20.11) |
| 2018 | $21.67 | 1 | Gilead Sciences, Inc. ($21.67) |
All Payment Transactions
535 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Bone Health | ||||||
| 12/18/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/17/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Endocrinology | ||||||
| 12/05/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/04/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Endocrinology | ||||||
| 11/21/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Bone Health | ||||||
| 11/21/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Diabetes Care | ||||||
| 11/15/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $29.18 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/13/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $21.15 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Cardio-renal | ||||||
| 11/06/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $60.06 | General |
| Category: Insulin Pump | ||||||
| 11/04/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $23.93 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 11/01/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $6.37 | General |
| Category: Endocrinology | ||||||
| 11/01/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: Endocrinology | ||||||
| 10/31/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/30/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.41 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $17.10 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 10/23/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/15/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.59 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 823 | 1,558 | $205,153 | $117,079 |
| 2022 | 7 | 664 | 1,277 | $167,861 | $88,805 |
| 2021 | 7 | 531 | 1,043 | $128,723 | $70,100 |
| 2020 | 7 | 239 | 289 | $39,319 | $22,459 |
Total Patients
2,257
Total Services
4,167
Medicare Billing
$298,443
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 381 | 944 | $140,375 | $86,139 | 61.4% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 97 | 136 | $21,760 | $11,469 | 52.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $15,960 | $6,383 | 40.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 81 | $8,282 | $5,159 | 62.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 17 | $3,808 | $2,280 | 59.9% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 18 | 18 | $4,050 | $1,772 | 43.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $3,825 | $1,434 | 37.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 29 | 42 | $2,730 | $1,096 | 40.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 131 | 231 | $3,003 | $735.37 | 24.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 16 | 16 | $1,360 | $611.68 | 45.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 301 | 717 | $114,720 | $64,947 | 56.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 87 | 87 | $24,795 | $9,949 | 40.1% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 63 | 85 | $13,565 | $7,339 | 54.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 42 | $4,746 | $2,773 | 58.4% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2022 | 20 | 22 | $4,575 | $2,215 | 48.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 149 | 300 | $3,900 | $962.16 | 24.7% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 15 | 24 | $1,560 | $619.09 | 39.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 213 | 515 | $82,400 | $49,225 | 59.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 98 | 98 | $27,860 | $12,026 | 43.2% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 29 | 31 | $4,960 | $2,885 | 58.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 30 | 36 | $4,068 | $2,201 | 54.1% |
| 10005 | Fine needle aspiration of first lesion using ultrasound guidance | Office | 2021 | 16 | 17 | $3,325 | $1,881 | 56.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 124 | 315 | $4,095 | $1,033 | 25.2% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 21 | 31 | $2,015 | $849.60 | 42.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 43 | 43 | $13,975 | $6,831 | 48.9% |
About Dr. Pablo Bedoya, M.D
Dr. Pablo Bedoya, M.D is a Internal Medicine healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1184800328.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pablo Bedoya, M.D has received a total of $9,984 in payments from pharmaceutical and medical device companies, with $2,939 received in 2024. These payments were reported across 535 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($9,773).
As a Medicare-enrolled provider, Bedoya has provided services to 2,257 Medicare beneficiaries, totaling 4,167 services with total Medicare billing of $298,443. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Richmond, VA
- Active Since 01/17/2008
- Last Updated 06/30/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1184800328
Products in Payments
- JARDIANCE (Drug) $564.28
- Omnipod (Device) $514.67
- FREESTYLE LIBRE 3 (Device) $500.16
- UNITHROID (Drug) $436.87
- MOUNJARO (Drug) $392.64
- EVENITY (Biological) $352.82
- Ozempic (Drug) $340.60
- Wegovy (Drug) $321.27
- Tymlos (Drug) $315.42
- FARXIGA (Drug) $297.79
- Repatha (Biological) $267.82
- JATENZO (Drug) $260.84
- LEQVIO (Drug) $256.30
- Rybelsus (Drug) $249.86
- STRENSIQ (Biological) $227.68
- LYUMJEV (Drug) $218.25
- NEXLETOL (Drug) $196.04
- Kerendia (Drug) $189.39
- FREESTYLE LIBRE 2 (Device) $163.49
- TZIELD (Biological) $155.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Richmond
Dr. George Vetrovec, M.d, M.D
Internal Medicine — Payments: $3.2M
Internal Medicine $3.2M
Dr. Arun Sanyal, M.d, M.D
Internal Medicine — Payments: $956,666
Internal Medicine $956,666
Dr. Erica Gregonis, Md, MD
Internal Medicine — Payments: $314,689
Internal Medicine $314,689
Dr. Lawrence Schwartz, M.d, M.D
Internal Medicine — Payments: $205,580
Internal Medicine $205,580
Dr. Wally Smith, M.d, M.D
Internal Medicine — Payments: $195,657
Internal Medicine $195,657
Dr. Gaurav Gupta, Md, MD
Internal Medicine — Payments: $189,406
Internal Medicine $189,406